Melox (Meloxicam)

Meloxicam works by selectively inhibiting the cyclooxygenase‑2 (COX‑2) enzyme, which reduces the production of prostaglandins that mediate inflammation, pain, and fever. This targeted action helps control inflammatory processes while sparing COX‑1 activity that protects the stomach lining.

The dosage of Melox is determined by the prescribing clinician based on the patient’s condition, severity, and response to therapy. Typical regimens may range from a single intramuscular injection to repeated doses, but exact amounts must be set by a qualified healthcare professional.

Safety data for meloxicam during pregnancy and lactation are limited, and the drug is generally classified as contraindicated or to be used only if the potential benefit outweighs the risk. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To order Melox, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain handling if needed) and necessary import documentation.

Melox (meloxicam) offers COX‑2 selectivity, which may provide a lower risk of gastrointestinal irritation compared with non‑selective NSAIDs such as ibuprofen or diclofenac. However, it shares similar cardiovascular and renal safety considerations, and the choice of NSAID should be individualized based on patient risk factors and therapeutic goals.

Melox should be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. Keep the product in its original packaging to maintain temperature stability and prevent moisture exposure until it is prepared for administration.

Melox is supplied as a sterile solution for intramuscular injection. The healthcare professional administers the dose into a suitable muscle, typically the gluteal or deltoid region, following aseptic technique and according to the prescribed regimen.

Serious risks include gastrointestinal bleeding or perforation, severe cardiovascular events such as heart attack or stroke, acute kidney injury, severe skin reactions like Stevens‑Johnson syndrome, and life‑threatening allergic responses. Patients should be monitored for signs of these conditions and seek immediate medical attention if they occur.

Melox is contraindicated in patients with known hypersensitivity to meloxicam or other NSAIDs, those with active gastrointestinal ulceration or bleeding, severe heart failure, and individuals who have experienced previous serious cardiovascular or renal events related to NSAID therapy. Clinicians should assess each patient’s medical history before prescribing.